Brian Stevenson

University of Pennsylvania, Philadelphia, PA, United States

Are you Brian Stevenson?

Claim your profile

Publications (104)377.06 Total impact

  • Source
    [show abstract] [hide abstract]
    ABSTRACT: The hypothesis that evolvability - the capacity to evolve by natural selection - is itself the object of natural selection is highly intriguing but remains controversial due in large part to a paucity of direct experimental evidence. The antigenic variation mechanisms of microbial pathogens provide an experimentally tractable system to test whether natural selection has favored mechanisms that increase evolvability. Many antigenic variation systems consist of paralogous unexpressed 'cassettes' that recombine into an expression site to rapidly alter the expressed protein. Importantly, the magnitude of antigenic change is a function of the genetic diversity among the unexpressed cassettes. Thus, evidence that selection favors among-cassette diversity is direct evidence that natural selection promotes antigenic evolvability. We used the Lyme disease bacterium, Borrelia burgdorferi, as a model to test the prediction that natural selection favors amino acid diversity among unexpressed vls cassettes and thereby promotes evolvability in a primary surface antigen, VlsE. The hypothesis that diversity among vls cassettes is favored by natural selection was supported in each B. burgdorferi strain analyzed using both classical (dN/dS ratios) and Bayesian population genetic analyses of genetic sequence data. This hypothesis was also supported by the conservation of highly mutable tandem-repeat structures across B. burgdorferi strains despite a near complete absence of sequence conservation. Diversification among vls cassettes due to natural selection and mutable repeat structures promotes long-term antigenic evolvability of VlsE. These findings provide a direct demonstration that molecular mechanisms that enhance evolvability of surface antigens are an evolutionary adaptation. The molecular evolutionary processes identified here can serve as a model for the evolution of antigenic evolvability in many pathogens which utilize similar strategies to establish chronic infections.
    PLoS Pathogens 11/2013; 9(11):e1003766. · 8.14 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: Bacteria require explicit control over their proteomes in order to compete and survive in dynamic environments. The Lyme disease spirochete, Borrelia burgdorferi, undergoes substantial protein profile changes during its cycling between vector ticks and vertebrate hosts. In an effort to understand regulation of these transitions, we recently isolated and functionally characterized the borrelial nucleic acid binding-protein Bpur, a PUR domain-containing protein. We now report that this regulatory protein governs its own synthesis through direct interactions with bpur mRNA. In vitro and in vivo techniques indicate that Bpur binds with high affinity and specificity to the 5' region of its message, thereby inhibiting translation. This negative feedback could permit the bacteria to fine-tune cellular Bpur concentrations. These data add to the understanding of this newly described class of prokaryotic DNA- and RNA-binding regulatory proteins.
    Journal of bacteriology 08/2013; · 3.94 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: The Lyme disease spirochete Borrelia burgdorferi lacks endogenous, surface-exposed proteases. In order to efficiently disseminate throughout the host and penetrate tissue barriers, borreliae rely on recruitment of host proteases such as plasmin(ogen). Here we report the identification of a novel plasminogen-binding protein, BBA70. Binding of plasminogen is dose-dependent and is not affected by ionic strength. The BBA70-plasminogen interaction is mediated by lysine residues, primarily located in a putative C-terminal α-helix of BBA70. These lysine residues appear to interact with the lysine-binding sites in plasminogen kringle domain 4, since a deletion mutant of plasminogen lacking that domain was unable to bind to BBA70. Bound to BBA70, plasminogen activated by urokinase-type plasminogen activator was able to degrade both a synthetic chromogenic substrate and the natural substrate fibrinogen. Furthermore, BBA70-bound plasmin was able to degrade the central complement proteins C3b and C5, and inhibited the bacteriolytic effects of complement. Consistent with these functional activities, BBA70 is located on the borrelial outer surface. Additionally, serological evidence demonstrated that BBA70 is produced during mammalian infection. Taken together, recruitment and activation of plasminogen could play a beneficial role in dissemination of B. burgdorferi in the human host and may possibly aid the spirochete in escaping the defense mechanisms of innate immunity.
    Journal of Biological Chemistry 07/2013; · 4.65 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: The PUR-domain is a nucleic acid-binding motif found in critical regulatory proteins of higher eukaryotes, and in certain species of bacteria. During investigations into mechanisms by which the Lyme disease spirochete controls synthesis of its Erp surface proteins, it was discovered that the borrelial PUR-domain protein, Bpur, binds with high affinity to double-stranded DNA adjacent to the erp transcriptional promoter. Bpur was found to enhance the effects of the erp repressor protein, BpaB. Bpur also bound single stranded DNA and RNA, with relative affinities RNA > double stranded DNA > single stranded DNA. Rational site-directed mutagenesis of Bpur identified amino acid residues and domains critical for interactions with nucleic acids, and revealed that the PUR-domain has a distinct mechanism of interaction with each type of nucleic acid ligand. These data shed light on both gene regulation in the Lyme spirochete and functional mechanisms of the widely-distributed PUR-domain.
    Journal of Biological Chemistry 07/2013; · 4.65 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Lyme disease spirochetes possess complex genomes, consisting of a main chromosome and 20 or more smaller replicons. Among those small DNAs are the cp32 elements, a family of prophages that replicate as circular episomes. All complete cp32s contain an erp locus, which encodes surface-exposed proteins. Sequences were compared for all 193 erp alleles carried by 22 different strains of Lyme spirochete, to investigate their natural diversity and evolutionary histories. These included multiple isolates from an endemic focus in the northeastern USA, and isolates from across North America and Europe. Bacteria were derived from diseased humans and from vector ticks, and included members of 5 different Borrelia genospecies. All erp operon 5' non-coding regions were found to be highly conserved, as are also the initial 70-80 bp of all erp open reading frames, indicative of a common evolutionary origin. However, the majority of the protein coding regions are highly diverse, due to numerous intra- and intergenic recombination events. Most erp alleles are chimeras derived from sequences of closely-related and distantly related erp sequences, and from unknown origins. Since known functions of Erp surface proteins involve interactions with various host tissue components, this diversity may reflect both their multiple functions and the abilities of Lyme spirochetes to successfully infect a wide variety of vertebrate host species.
    Applied and environmental microbiology 04/2013; · 3.69 Impact Factor
  • Ashutosh Verma, Brian Stevenson, Ben Adler
    [show abstract] [hide abstract]
    ABSTRACT: Leptospirosis in horses has been considered a relatively uncommon infection. However, recent data suggest that the infection is widespread, with the incidence and infecting serovars varying considerably in different geographical regions. The majority of infections remain asymptomatic. Clinical signs in equine leptospirosis resemble those seen in other animal species. However, leptospirosis as a cause of acute respiratory distress is becoming more frequently recognised. A particular feature of equine leptospirosis is post infection recurrent uveitis (moon blindness or periodic ophthalmia), which appears to be mediated by autoimmune mechanisms involving cross reactivity between ocular tissues and leptospiral membrane proteins. There are no leptospiral vaccines licensed for use in horses, with no prospect for any becoming available in the foreseeable future. Accordingly, prevention of equine leptospirosis must rely on good hygiene practices, minimisation of rodent contact, and vaccination of other species of production and companion animals.
    Veterinary Microbiology 04/2013; · 3.13 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: A site-specific DNA-binding protein was purified from Borrelia burgdorferi cytoplasmic extracts, and determined to be a member of the highly conserved SpoVG family. This is the first time a function has been attributed to any of these ubiquitous bacterial proteins. Further investigations into SpoVG orthologues indicated that the Staphylococcus aureus protein also binds DNA, but interacts preferentially with a distinct nucleic acid sequence. Site-directed mutagenesis and domain swapping between the S. aureus and B. burgdorferi proteins identified that a 6-residue stretch of the SpoVG α-helix contributes to DNA sequence specificity. Two additional, highly conserved amino acid residues on an adjacent β-sheet are essential for DNA-binding, apparently by contacts with the DNA phosphate backbone. Results of these studies thus identified a novel family of bacterial DNA-binding proteins, developed a model of SpoVG-DNA interactions, and provide direction for future functional studies on these wide-spread proteins.
    PLoS ONE 01/2013; 8(6):e66683. · 3.73 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: The Lyme disease spirochete controls production of its OspC and Erp outer surface proteins, repressing protein synthesis during colonization of vector ticks but increasing expression when those ticks feed on vertebrate hosts. Early studies found that synthesis of OspC and Erps can be stimulated in culture by shifting temperature from 23 to 34°C, leading to a hypothesis that B. burgdorferi senses environmental temperature to determine its location in the tick-mammal infectious cycle. However, borreliae cultured at 34°C divide several times faster than do those cultured at 23°C. We developed methods that disassociate bacterial growth rate and temperature, allowing separate evaluation of each factor's impacts on B. burgdorferi gene and protein expression. Altogether, the data support a new paradigm that B. burgdorferi actually responds to changes in its own replication rate, not temperature per se, as the impetus to increase expression of the OspC and Erp infection-associated proteins.
    Journal of bacteriology 12/2012; · 3.94 Impact Factor
  • Peter Kraiczy, Brian Stevenson
    [show abstract] [hide abstract]
    ABSTRACT: Borrelia burgdorferi, the etiological agent of Lyme disease, exploits an array of strategies to establish infection and to overcome host innate and adaptive immune responses. One key borrelial immune escape mechanism involves the inactivation of host complement attack through acquisition of human immune regulators factor H (CFH), factor H-like protein 1 (FHL1), factor H-related protein 1 (CFHR1), CFHR2, and/or CFHR5. Binding of these host proteins is primarily mediated by bacterial surface-exposed proteins that have been collectively referred to as complement regulator-acquiring surface proteins, or CRASPs. Different strains of B. burgdorferi produce as many as 5 different CRASP molecules that comprise 3 distinct, genetically unrelated groups. Depending on bacterial genetic composition, different combinations of these proteins can be found on the borrelial outer surface. The 3 groups differ in their gene location, gene regulatory mechanisms, expression patterns during the tick-mammal infection cycle, protein sequence and structure as well as binding affinity for complement regulators and other serum proteins. These attributes influence the proteins' abilities to contribute to complement resistance of this emerging human pathogen. In this review, we focus on the current knowledge on structure, function, and gene regulation of these B. burgdorferi infection-associated proteins.
    Ticks and Tick-borne Diseases 11/2012; · 2.35 Impact Factor
  • Ashutosh Verma, Brian Stevenson
    Zoonoses and Public Health. 09/2012; Suppl 2:132-41.
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: The Borrelia burgdorferi BpaB proteins of the spirochete's ubiquitous cp32 prophages are DNA-binding proteins, required both for maintenance of the bacteriophage episomes and for transcriptional regulation of the cp32 erp operons. Through use of DNase I footprinting, we demonstrate that BpaB binds the erp operator initially at the sequence 5'-TTATA-3'. Electrophoretic mobility shift assays indicated that BpaB also binds with high affinity to sites located in the 5' noncoding regions of two additional cp32 genes. Characterization of the proteins encoded by those genes indicated that they are a single-stranded DNA-binding protein and a nuclease, which we named SsbP and NucP, respectively. Chromatin immunoprecipitation indicated that BpaB binds erp, ssbP, and nucP in live B. burgdorferi. A mutant bacterium that overexpressed BpaB produced significantly higher levels of ssbP and nucP transcript than did the wild-type parent.
    Journal of bacteriology 06/2012; 194(17):4570-8. · 3.94 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Nearly every known species of Eubacteria encodes a homolog of the Borrelia burgdorferi EbfC DNA-binding protein. We now demonstrate that fluorescently tagged EbfC associates with B. burgdorferi nucleoids in vivo and that chromatin immunoprecipitation (ChIP) of wild-type EbfC showed it to bind in vivo to sites throughout the genome, two hallmarks of nucleoid-associated proteins. Comparative RNA sequencing (RNA-Seq) of a mutant B. burgdorferi strain that overexpresses EbfC indicated that approximately 4.5% of borrelial genes are significantly impacted by EbfC. The ebfC gene was highly expressed in rapidly growing bacteria, but ebfC mRNA was undetectable in stationary phase. Combined with previous data showing that EbfC induces bends in DNA, these results demonstrate that EbfC is a nucleoid-associated protein and lead to the hypothesis that B. burgdorferi utilizes cellular fluctuations in EbfC levels to globally control transcription of numerous genes. The ubiquity of EbfC proteins in Eubacteria suggests that these results apply to a wide range of pathogens and other bacteria.
    Journal of bacteriology 04/2012; 194(13):3395-406. · 3.94 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Screening of an expression library of Leptospira interrogans with eye fluids from uveitic horses resulted in identification of a novel protein, LruC. LruC is located in the inner leaflet of the leptospiral outer membrane, and an lruC gene was detected in all tested pathogenic L. interrogans strains. LruC-specific antibody levels were significantly higher in eye fluids and sera of uveitic horses than healthy horses. These findings suggest that LruC may play a role in equine leptospiral uveitis.
    Clinical and vaccine Immunology: CVI 03/2012; 19(3):452-6. · 2.60 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: In little more than 30 years, Lyme disease, which is caused by the spirochaete Borrelia burgdorferi, has risen from relative obscurity to become a global public health problem and a prototype of an emerging infection. During this period, there has been an extraordinary accumulation of knowledge on the phylogenetic diversity, molecular biology, genetics and host interactions of B. burgdorferi. In this Review, we integrate this large body of information into a cohesive picture of the molecular and cellular events that transpire as Lyme disease spirochaetes transit between their arthropod and vertebrate hosts during the enzootic cycle.
    Nature Reviews Microbiology 02/2012; 10(2):87-99. · 22.49 Impact Factor
  • Source
    Brandon L Jutras, Ashutosh Verma, Brian Stevenson
    [show abstract] [hide abstract]
    ABSTRACT: This units presents methods through which one may isolate and identify novel bacterial DNA-binding proteins. Briefly, the DNA sequence of interest is affixed to beads, and then incubated with bacterial cytoplasmic extract. Washes with buffers containing nonspecific DNA and low-salt concentrations will remove non-adhering and low-specificity DNA-binding proteins, while subsequent washes with higher salt concentrations will elute more specific DNA-binding proteins. Eluted proteins may then be identified by standard proteomic techniques.
    Current protocols in microbiology 02/2012; Chapter 1:Unit1F.1.
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Borrelia burgdorferi evades complement-mediated killing by interacting with complement regulators through distinct complement regulator-acquiring surface proteins (CRASPs). Here, we extend our analyses to the contribution of CRASP-4 in mediating complement resistance of B. burgdorferi and its interaction with human complement regulators. CRASP-4 (also known as ErpC) was immobilized onto magnetic beads and used to capture proteins from human serum. Following Western blotting, factor H (CFH), CFH-related protein 1 (CFHR1), CFHR2, and CFHR5 were identified as ligands of CRASP-4. To analyze the impact of native CRASP-4 on mediating survival of serum-sensitive cells in human serum, a B. garinii strain was generated that ectopically expresses CRASP-4. CRASP-4-producing bacteria bound CFHR1, CFHR2, and CFHR5 but not CFH. In addition, transformed spirochetes deposited significant amounts of lethal complement components on their surface and were susceptible to human serum, thus indicating that CRASP-4 plays a subordinate role in complement resistance of B. burgdorferi.
    Clinical and Developmental Immunology 01/2012; 2012:349657. · 3.06 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Vector-borne pathogens regulate their protein expression profiles, producing factors during host infection that differ from those produced during vector colonization. The Lyme disease agent, Borrelia burgdorferi, produces Erp surface proteins throughout mammalian infection and represses their synthesis during colonization of vector ticks. Known functions of Erp proteins include binding of host laminin, plasmin(ogen), and regulators of complement activation. A DNA region immediately 5' of erp operons, the erp operator, is required for transcriptional regulation. The B. burgdorferi BpaB and EbfC proteins exhibit high in vitro affinities for erp operator DNA. In the present studies, chromatin immunoprecipitation (ChIP) demonstrated that both proteins bind erp operator DNA in vivo. Additionally, a combination of in vivo and in vitro methods demonstrated that BpaB functions as a repressor of erp transcription, while EbfC functions as an antirepressor.
    Journal of bacteriology 12/2011; 194(4):778-86. · 3.94 Impact Factor
  • Molecular Immunology - MOL IMMUNOL. 01/2011; 48(14):1697-1697.
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Borrelia burgdorferi produces Erp outer surface proteins throughout mammalian infection, but represses their synthesis during colonization of vector ticks. A DNA region 5' of the start of erp transcription, Operator 2, was previously shown to be essential for regulation of expression. We now report identification and characterization of a novel erp Operator 2-binding protein, which we named BpaB. erp operons are located on episomal cp32 prophages, and a single bacterium may contain as many as 10 different cp32s. Each cp32 family member encodes a unique BpaB protein, yet the three tested cp32-encoded BpaB alleles all bound to the same DNA sequence. A 20-bp region of erp Operator 2 was determined to be essential for BpaB binding, and initial protein binding to that site was required for binding of additional BpaB molecules. A 36-residue region near the BpaB carboxy terminus was found to be essential for high-affinity DNA-binding. BpaB competed for binding to erp Operator 2 with a second B. burgdorferi DNA-binding protein, EbfC. Thus, cellular levels of free BpaB and EbfC could potentially control erp transcription levels.
    Nucleic Acids Research 09/2010; 38(16):5443-55. · 8.28 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Previous studies using small numbers of serum samples from human patients and experimentally infected animals identified the frequent presence of antibodies recognizing RevA, a borrelial fibronectin-binding outer surface protein. We now demonstrate that most examined Lyme disease spirochetes from North America and Europe contain genes encoding RevA proteins, some with extensive regions of conservation and others with moderate diversity. Line blot analyses using recombinant RevA from two diverse Lyme disease spirochetes of RevA and serum samples from culture-confirmed human Lyme disease patients from the United States (n = 46, mainly with early Lyme disease) and Germany (>500, with early and late manifestations of Lyme disease) were performed. The results indicated that a sizable proportion of patients produced antibodies that recognized recombinant RevA. Overall, RevA-based serological studies were less sensitive and less specific than other assay types, such as the VlsE-based C6 peptide assay. However, sera from patients in the initial stages of Lyme disease contained antibodies against RevA, demonstrating that this protein is expressed early in human infection. Thus, RevA may be a useful target for preventative or curative therapies.
    Clinical and vaccine Immunology: CVI 02/2010; 17(2):274-80. · 2.60 Impact Factor

Publication Stats

3k Citations
534 Downloads
377.06 Total Impact Points

Institutions

  • 2013
    • University of Pennsylvania
      • Department of Biology
      Philadelphia, PA, United States
  • 2005–2013
    • University Hospital Frankfurt
      Frankfurt, Hesse, Germany
  • 2000–2013
    • University of Kentucky
      • • Department of Microbiology, Immunology & Molecular Genetics
      • • Department of Veterinary Science
      Lexington, KY, United States
    • National Institutes of Health
      • Laboratory of Human Bacterial Pathogenesis (LHBP)
      Bethesda, MD, United States
  • 2004–2012
    • Goethe-Universität Frankfurt am Main
      • Zentrum der Hygiene
      Frankfurt am Main, Hesse, Germany
  • 2009
    • Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute
      • Department of Infection Biology
      Jena, Thuringia, Germany
  • 2008
    • Heidelberg University
      • Department of Immunology and Serology
      Heidelberg, Baden-Wuerttemberg, Germany
  • 2007
    • Medical University of Ohio at Toledo
      • Department of Medical Microbiology and Immunology
      Toledo, Ohio, United States
  • 2006
    • University of Texas Medical School
      • Department of Microbiology and Molecular Genetics
      Houston, Texas, United States
  • 1995–2001
    • National Institute of Allergy and Infectious Diseases
      Maryland, United States
  • 1998
    • University of California, Davis
      • Center for Comparative Medicine
      Davis, CA, United States
  • 1997
    • University of Utah
      • Department of Oncological Sciences
      Salt Lake City, UT, United States
  • 1996
    • University of Montana
      • Division of Biological Sciences
      Missoula, Montana, United States
  • 1994–1995
    • Yale University
      • Section of Comparative Medicine
      New Haven, CT, United States